Cambridge Investment Research Advisors Inc. Grows Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Cambridge Investment Research Advisors Inc. boosted its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 357,520 shares of the real estate investment trust's stock after acquiring an additional 23,135 shares during the quarter. Cambridge Investment Research Advisors Inc. owned about 0.05% of Healthpeak Properties worth $7,229,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of DOC. Mizuho Bank Ltd. bought a new stake in shares of Healthpeak Properties in the 4th quarter worth approximately $28,000. Harvest Fund Management Co. Ltd acquired a new position in Healthpeak Properties in the fourth quarter worth approximately $30,000. Future Financial Wealth Managment LLC purchased a new stake in Healthpeak Properties during the first quarter valued at about $30,000. Covestor Ltd lifted its holdings in shares of Healthpeak Properties by 173.8% in the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after purchasing an additional 1,152 shares in the last quarter. Finally, Beacon Capital Management LLC boosted its stake in shares of Healthpeak Properties by 138.3% during the 1st quarter. Beacon Capital Management LLC now owns 1,816 shares of the real estate investment trust's stock valued at $37,000 after buying an additional 1,054 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.

Insider Activity at Healthpeak Properties

In other news, CEO Scott M. Brinker acquired 11,337 shares of the business's stock in a transaction that occurred on Monday, April 28th. The shares were bought at an average price of $17.68 per share, with a total value of $200,438.16. Following the acquisition, the chief executive officer now directly owns 201,863 shares in the company, valued at $3,568,937.84. The trade was a 5.95% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Tommy G. Thompson purchased 5,700 shares of the stock in a transaction on Friday, May 9th. The shares were purchased at an average price of $17.36 per share, with a total value of $98,952.00. Following the acquisition, the director now owns 138,513 shares in the company, valued at approximately $2,404,585.68. The trade was a 4.29% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 29,764 shares of company stock valued at $521,909 over the last ninety days. 0.23% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have commented on DOC. Scotiabank decreased their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research report on Monday, May 12th. Wedbush dropped their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Wells Fargo & Company decreased their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, June 2nd. Argus reiterated a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Finally, Wall Street Zen downgraded Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Saturday, June 21st. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $23.27.

Healthpeak Properties Price Performance

Healthpeak Properties stock traded down $0.14 during mid-day trading on Friday, reaching $17.35. 9,420,686 shares of the company were exchanged, compared to its average volume of 5,258,622. The firm has a market cap of $12.05 billion, a PE ratio of 43.36, a PEG ratio of 1.97 and a beta of 1.04. The company has a fifty day simple moving average of $17.50 and a 200-day simple moving average of $19.16. Healthpeak Properties, Inc. has a 12 month low of $16.64 and a 12 month high of $23.26. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.35 and a quick ratio of 1.35.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. The firm had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The business's revenue for the quarter was up 15.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.45 earnings per share. As a group, equities research analysts expect that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. The ex-dividend date of this dividend was Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties's dividend payout ratio (DPR) is currently 305.00%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.